Enanta Pharmaceuticals (ENTA) Common Equity (2012 - 2026)
Enanta Pharmaceuticals (ENTA) reported Common Equity of $101.07 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 27.5% from $79.28 million a year earlier but down 13.3% from the prior quarter.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Common Equity (2012 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals posted Common Equity of $64.72 million, down 49.8% from FY2024.
- Common Equity has declined for six consecutive fiscal years, with a five-year compound annual growth rate of -32.3% (FY2020 to FY2025).
- By fiscal year, Common Equity came in at $128.81 million in FY2024 (-40.6%), $216.74 million in FY2023 (-32.6%), $321.33 million in FY2022 (-19.6%) and $399.43 million in FY2021 (-12.3%).
- Five-year quarterly Common Equity spans a low of $64.72 million in fiscal Q4 2025 and a high of $399.43 million in fiscal Q4 2021.
- Year over year, Common Equity has now increased in each of the last three quarters, with an average decline of 19.6% over the last eight quarters.
- The high point for year-over-year Common Equity in five years was fiscal Q3 2026 (growth of 27.5%); the low point was fiscal Q4 2025 (a decline of 49.8%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $116.59 million (Q2 2026), $126.59 million (Q1 2026) and $64.72 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Enanta Pharmaceuticals | 367.20 Mn | -360.79 Mn | - | 101.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 101.07 Mn |
| Mar 31, 2026 | 116.59 Mn |
| Dec 31, 2025 | 126.59 Mn |
| Sep 30, 2025 | 64.72 Mn |
| Jun 30, 2025 | 79.28 Mn |
| Mar 31, 2025 | 93.54 Mn |
| Dec 31, 2024 | 111.82 Mn |
| Sep 30, 2024 | 128.81 Mn |
| Jun 30, 2024 | 148.92 Mn |
| Mar 31, 2024 | 166.11 Mn |
| Dec 31, 2023 | 191.88 Mn |
| Sep 30, 2023 | 216.74 Mn |
| Jun 30, 2023 | 237.82 Mn |
| Mar 31, 2023 | 269.38 Mn |
| Dec 31, 2022 | 300.84 Mn |
| Sep 30, 2022 | 321.33 Mn |
| Jun 30, 2022 | 338.02 Mn |
| Mar 31, 2022 | 358.58 Mn |
| Dec 31, 2021 | 384.38 Mn |
| Sep 30, 2021 | 399.43 Mn |
API Access
Enanta Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();